Sponsor or institution
Clinical trials and research at Shanghai Allink Biotherapeutics Co., Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Shanghai Allink Biotherapeutics Co., Ltd. that are recruiting, at sites in 3 countries (most in Australia (2), United States (2), China (1)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Evaluating ALK202 for advanced solid tumors
This study is testing a new drug called ALK202 to see if it is safe and effective for adults with advanced solid tumors.
-
Evaluating ALK201 for advanced solid tumors
This study is testing a new drug called ALK201 to see if it is safe and effective for adults with advanced solid tumors.
Quick answers
How many clinical trials run by Shanghai Allink Biotherapeutics Co., Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Australia (2 trials), United States (2 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.